PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930139
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930139
The global ureteroscope market has been witnessing steady expansion, driven by the rising prevalence of urinary stone disease and increasing adoption of minimally invasive urological procedures. According to Fortune Business Insights, the market was valued at USD 1.34 billion in 2025 and is projected to grow to USD 1.42 billion in 2026. By 2034, the global ureteroscope market is forecast to reach USD 2.24 billion, registering a compound annual growth rate (CAGR) of 5.91% during the forecast period (2026-2034).
In 2025, North America dominated the global market with a share of 36.03%, supported by advanced healthcare infrastructure and high procedural volumes.
Market Drivers
Rising Prevalence of Urolithiasis
The increasing incidence of urolithiasis is a primary factor driving ureteroscope demand worldwide. Globally, urinary stone disease affects nearly 15% of the population, with lifestyle changes, dietary habits, global warming, alcohol consumption, and metabolic disorders contributing to disease growth. In the United States alone, kidney stones affect approximately 9% of the population, resulting in a rising number of ureteroscopic procedures. As a result, demand for advanced ureteroscopes continues to grow steadily from 2025 onward.
Technological Advancements
Technological innovation plays a vital role in market expansion. The shift from conventional rigid devices to flexible and digital ureteroscopes has improved visualization, maneuverability, and procedural success rates. Digital imaging, enhanced optics, and improved durability have strengthened the adoption of flexible ureteroscopy for stone removal and diagnostic procedures, particularly during the 2026-2034 forecast period.
Market Restraints
Despite strong growth potential, the market faces challenges. High costs of digital and single-use ureteroscopes, combined with limited reimbursement in developing regions, restrict adoption. Additionally, ureteroscopy requires highly skilled professionals, and shortages of trained urologists in economically weaker regions may hamper market expansion during the forecast period.
Market Segmentation Analysis
By Product Type
Based on product type, the market is segmented into flexible, semi-flexible, and rigid ureteroscopes. The flexible ureteroscope segment held the largest market share, accounting for 57.19% in 2026, due to higher procedural success rates and increasing preference for minimally invasive interventions. Continuous innovations in fiber-optic and digital flexible ureteroscopes are expected to reduce the utilization of rigid devices in the coming years.
By Application
By application, the market is categorized into urolithiasis, urothelial cancer, and others. The urolithiasis segment dominated the market, contributing 74.79% of global revenue in 2026, reflecting the growing burden of urinary stones and the effectiveness of ureteroscopy compared to alternative treatment methods.
By End User
In terms of end users, the market includes hospitals, specialty clinics, and others. The hospital segment led the market, accounting for 55.74% in 2026, due to better infrastructure, availability of skilled healthcare professionals, and favorable reimbursement policies.
North America recorded a market size of USD 0.48 billion in 2025, driven by high procedure volumes and affordability of advanced ureteroscopes.
Europe held the second-largest share, supported by a growing geriatric population and increasing product approvals.
The Asia Pacific region is expected to grow at a faster pace during the forecast period due to rising healthcare expenditure and expanding presence of key manufacturers in China, India, and Japan. By 2026, Japan, China, and India are projected to reach USD 0.07 billion, USD 0.09 billion, and USD 0.03 billion, respectively.
Competitive Landscape
The ureteroscope market is moderately consolidated, with key players such as Olympus Corporation, Boston Scientific Corporation, Stryker, KARL STORZ, and Richard Wolf GmbH. Major companies focus on product innovation, single-use devices, and expansion in emerging markets to strengthen their global presence.
Conclusion
In conclusion, the global ureteroscope market is poised for sustained growth from USD 1.34 billion in 2025 to USD 2.24 billion by 2034, driven by the rising prevalence of urolithiasis, technological advancements, and increasing adoption of minimally invasive urological procedures. While high device costs and limited skilled workforce remain challenges, continuous innovation and expanding healthcare infrastructure-especially in Asia Pacific-are expected to support long-term market growth during the forecast period.
Segmentation
By Product
By Application
By End User
By Geography